Recently, telomerase reverse transcriptase (TERT) has emerged as a novel potential therapeutic target for treating GBM.5 TERT expression is the most common mechanism by which cancers maintain telomere length and achieve immortality, and up-regulation of TERT expression due to TERT promoter mutations is a prominent genetic feature in GBM. The gene discussed is TERT; the disease is cancer.